Reverse transcriptase inhibitors diminish systemic proinflammatory responses to bacterial pathogens by Karthik Hullahalli, Katherine G. Dailey, Ryan Acbay, Masataka Suzuki, George I. Balazs, Matthew K. Waldor

Subjects: “…reverse transcriptase inhibitors…”
Get full text

Expanding treatment eligibility for chronic hepatitis B: Balancing benefits, limitations, and healthcare access: Correspondence to editorial on “Antiviral therapy for chronic hepat... by Yao-Chun Hsu, Chi-Yi Chen, Jaw-Town Lin

Subjects: Get full text

Spectrum of Non-Nucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living with HIV-1 Receiving Rilpivirine by Pavithra Nagarajan, Jinru Zhou, Giulia Di Teodoro, Francesca Incardona, Carole Seguin-Devaux, Rolf Kaiser, Ana B. Abecasis, Perpetua Gomes, Kaiming Tao, Maurizio Zazzi, Robert W. Shafer

Subjects: “…non-nucleoside reverse transcriptase inhibitors…”
Get full text

Cumulative effects of hypertriglyceridemia in HIV-infected patients switching from NNRTIs to PI-based antiretroviral therapy by Yu Zhang, Jiang Xiao, Wen Zhang, Ning Han, Di Yang, Wei Liu, Hui Zeng, Junyan Han, Hongxin Zhao

Subjects: “…Non-nucleoside reverse transcriptase inhibitors…”
Get full text

ANALYSIS OF ADVERSE DRUG REACTION REPORT FORMS ON THE MEDICINES, USED FOR AIDS TREATMENT (REGISTERED IN THE REPUBLIC OF CRIMEA IN THE PERIOD FROM 2011 TO 2016) by A. V. Matveev, A. Е. Krasheninnikov, E. A. Egorova, E. I. Konyaeva

Subjects: “…nucleoside reverse transcriptase inhibitors…”
Get full text

Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study by Stefania Cicalini, Simone Lanini, Roberta Gagliardini, Rita Bellagamba, Alessandra Vergori, Ilaria Mastrorosa, Valentina Mazzotta, Rozenn Esvan, Maria Maddalena Plazzi, Sandrine Ottou, Elisabetta Grilli, Federico De Zottis, Marisa Fusto, Jessica Paulicelli, Andrea Antinori

Subjects: “…non-nucleoside reverse transcriptase inhibitors (NNRTIs)…”
Get full text

Potential to use of viral reverse transcriptase inhibitors in oncology by O. A. Vlasova, I. A. Antonova, Kh. M. Magomedova, M. A. Usolkina, K. I. Kirsanov, G. A. Belitsky, T. T. Valiev, M. G. Yakubovskaya

Subjects: “…reverse transcriptase inhibitors…”
Get full text

Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatmen... by Davy-Hyacinthe Gouissi Anguechia, Yagai Bouba, Ezechiel Ngoufack Jagni Semengue, Aude Christelle Ka’e, Désiré Takou, Collins Ambe Chenwi, Grace Beloumou, Alex Durand Nka, Ulrich Roland Basseck Wome, Maria Mercedes Santoro, Francesca Ceccherini-Silberstein, Adawaye Chatté, Carla Montesano, Giulia Cappelli, Vittorio Colizzi, Alexis Ndjolo, Dora Mbanya, Nicaise Ndembi, Carlo-Federico Perno, Joseph Fokam

Subjects: “…non-nucleosides reverse transcriptase inhibitors…”
Get full text

Effect of the reverse transcriptase inhibitor efavirenz on 5-azacytidine-induced LINE1 long interspersed repeat expression and genetic instability in acute myeloid leukemia cells by Kh. M. Magomedova, I. A. Antonova, M. S. Strelkov, V. A. Nurtdinova, V. T. Cheshchevik, K. I. Kirsanov, G. A. Belitsky, M. G. Yakubovskaya, O. A. Vlasova

Subjects: “…retroviral reverse transcriptase inhibitor…”
Get full text